<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xml:base="https://www.tellmeproject.eu/taxonomy/term/98/all" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:fb="http://www.facebook.com/2008/fbml" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:og="http://ogp.me/ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:sioc="http://rdfs.org/sioc/ns#" xmlns:sioct="http://rdfs.org/sioc/types#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#">
  <channel>
    <title>zanamivir</title>
    <link>https://www.tellmeproject.eu/taxonomy/term/98/all</link>
    <description></description>
    <language>en</language>
     <atom:link href="https://www.tellmeproject.eu/taxonomy/term/98/all/feed" rel="self" type="application/rss+xml" />
      <item>
    <title>Tamiflu and Relenza effectiveness questioned by Cochrane Collaboration and BMJ</title>
    <link>https://www.tellmeproject.eu/content/tamiflu-and-relenza-effectiveness-questioned-cochrane-collaboration-and-bmj</link>
    <description>&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; property=&quot;content:encoded&quot;&gt;&lt;p&gt;There is no good evidence about the effectiveness of Tamiflu (oseltamivir) and Relenza (zanamivir) for influenza prevention and treatment. This is the tough claim made by Cochrane Collaboration and the British Medical Journal (BMJ), based on the extended systematic review they just published about the use of neuraminidase inhibitors against influenza.&lt;/p&gt;&lt;p&gt;Their study is entirely based on complete clinical study reports, trial registries, electronic databases, regulatory archives and correspondence with manufacturers, which correspond to more than 150,000 pages of documents; more specifically, the&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-tags field-type-taxonomy-term-reference field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Tags:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/antiviral-therapies&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Antiviral Therapies&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/antivirals&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Antivirals&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/oseltamivir&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Oseltamivir&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/zanamivir&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;zanamivir&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description>
     <pubDate>Thu, 10 Apr 2014 06:00:23 +0000</pubDate>
 <dc:creator>amministratore</dc:creator>
 <guid isPermaLink="false">251 at https://www.tellmeproject.eu</guid>
  </item>
  <item>
    <title>Tamiflu and Relenza effectiveness questioned by Cochrane Collaboration and BMJ</title>
    <link>https://www.tellmeproject.eu/content/tamiflu-and-relenza-effectiveness-questioned-cochrane-collaboration-and-bmj</link>
    <description>&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; property=&quot;content:encoded&quot;&gt;&lt;p&gt;There is no good evidence about the effectiveness of Tamiflu (oseltamivir) and Relenza (zanamivir) for influenza prevention and treatment. This is the tough claim made by Cochrane Collaboration and the British Medical Journal (BMJ), based on the extended systematic review they just published about the use of neuraminidase inhibitors against influenza.&lt;/p&gt;&lt;p&gt;Their study is entirely based on complete clinical study reports, trial registries, electronic databases, regulatory archives and correspondence with manufacturers, which correspond to more than 150,000 pages of documents; more specifically, the&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-tags field-type-taxonomy-term-reference field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Tags:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/antiviral-therapies&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Antiviral Therapies&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/antivirals&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Antivirals&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/oseltamivir&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Oseltamivir&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/zanamivir&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;zanamivir&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description>
     <pubDate>Thu, 10 Apr 2014 06:00:23 +0000</pubDate>
 <dc:creator>amministratore</dc:creator>
 <guid isPermaLink="false">251 at https://www.tellmeproject.eu</guid>
  </item>
  <item>
    <title>Tamiflu and Relenza effectiveness questioned by Cochrane Collaboration and BMJ</title>
    <link>https://www.tellmeproject.eu/content/tamiflu-and-relenza-effectiveness-questioned-cochrane-collaboration-and-bmj</link>
    <description>&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; property=&quot;content:encoded&quot;&gt;&lt;p&gt;There is no good evidence about the effectiveness of Tamiflu (oseltamivir) and Relenza (zanamivir) for influenza prevention and treatment. This is the tough claim made by Cochrane Collaboration and the British Medical Journal (BMJ), based on the extended systematic review they just published about the use of neuraminidase inhibitors against influenza.&lt;/p&gt;&lt;p&gt;Their study is entirely based on complete clinical study reports, trial registries, electronic databases, regulatory archives and correspondence with manufacturers, which correspond to more than 150,000 pages of documents; more specifically, the&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-tags field-type-taxonomy-term-reference field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Tags:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/antiviral-therapies&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Antiviral Therapies&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/antivirals&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Antivirals&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/oseltamivir&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Oseltamivir&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/zanamivir&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;zanamivir&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description>
     <pubDate>Thu, 10 Apr 2014 06:00:23 +0000</pubDate>
 <dc:creator>amministratore</dc:creator>
 <guid isPermaLink="false">251 at https://www.tellmeproject.eu</guid>
  </item>
  <item>
    <title>Tamiflu and Relenza effectiveness questioned by Cochrane Collaboration and BMJ</title>
    <link>https://www.tellmeproject.eu/content/tamiflu-and-relenza-effectiveness-questioned-cochrane-collaboration-and-bmj</link>
    <description>&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; property=&quot;content:encoded&quot;&gt;&lt;p&gt;There is no good evidence about the effectiveness of Tamiflu (oseltamivir) and Relenza (zanamivir) for influenza prevention and treatment. This is the tough claim made by Cochrane Collaboration and the British Medical Journal (BMJ), based on the extended systematic review they just published about the use of neuraminidase inhibitors against influenza.&lt;/p&gt;&lt;p&gt;Their study is entirely based on complete clinical study reports, trial registries, electronic databases, regulatory archives and correspondence with manufacturers, which correspond to more than 150,000 pages of documents; more specifically, the&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-tags field-type-taxonomy-term-reference field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Tags:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/antiviral-therapies&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Antiviral Therapies&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/antivirals&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Antivirals&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/oseltamivir&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Oseltamivir&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/zanamivir&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;zanamivir&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description>
     <pubDate>Thu, 10 Apr 2014 06:00:23 +0000</pubDate>
 <dc:creator>amministratore</dc:creator>
 <guid isPermaLink="false">251 at https://www.tellmeproject.eu</guid>
  </item>
  <item>
    <title>Tamiflu and Relenza effectiveness questioned by Cochrane Collaboration and BMJ</title>
    <link>https://www.tellmeproject.eu/content/tamiflu-and-relenza-effectiveness-questioned-cochrane-collaboration-and-bmj</link>
    <description>&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; property=&quot;content:encoded&quot;&gt;&lt;p&gt;There is no good evidence about the effectiveness of Tamiflu (oseltamivir) and Relenza (zanamivir) for influenza prevention and treatment. This is the tough claim made by Cochrane Collaboration and the British Medical Journal (BMJ), based on the extended systematic review they just published about the use of neuraminidase inhibitors against influenza.&lt;/p&gt;&lt;p&gt;Their study is entirely based on complete clinical study reports, trial registries, electronic databases, regulatory archives and correspondence with manufacturers, which correspond to more than 150,000 pages of documents; more specifically, the&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-tags field-type-taxonomy-term-reference field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Tags:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/antiviral-therapies&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Antiviral Therapies&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/antivirals&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Antivirals&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/oseltamivir&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Oseltamivir&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/zanamivir&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;zanamivir&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description>
     <pubDate>Thu, 10 Apr 2014 06:00:23 +0000</pubDate>
 <dc:creator>amministratore</dc:creator>
 <guid isPermaLink="false">251 at https://www.tellmeproject.eu</guid>
  </item>
  <item>
    <title>Tamiflu and Relenza effectiveness questioned by Cochrane Collaboration and BMJ</title>
    <link>https://www.tellmeproject.eu/content/tamiflu-and-relenza-effectiveness-questioned-cochrane-collaboration-and-bmj</link>
    <description>&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; property=&quot;content:encoded&quot;&gt;&lt;p&gt;There is no good evidence about the effectiveness of Tamiflu (oseltamivir) and Relenza (zanamivir) for influenza prevention and treatment. This is the tough claim made by Cochrane Collaboration and the British Medical Journal (BMJ), based on the extended systematic review they just published about the use of neuraminidase inhibitors against influenza.&lt;/p&gt;&lt;p&gt;Their study is entirely based on complete clinical study reports, trial registries, electronic databases, regulatory archives and correspondence with manufacturers, which correspond to more than 150,000 pages of documents; more specifically, the&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-tags field-type-taxonomy-term-reference field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Tags:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/antiviral-therapies&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Antiviral Therapies&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/antivirals&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Antivirals&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/oseltamivir&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Oseltamivir&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/zanamivir&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;zanamivir&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description>
     <pubDate>Thu, 10 Apr 2014 06:00:23 +0000</pubDate>
 <dc:creator>amministratore</dc:creator>
 <guid isPermaLink="false">251 at https://www.tellmeproject.eu</guid>
  </item>
  <item>
    <title>Tamiflu and Relenza effectiveness questioned by Cochrane Collaboration and BMJ</title>
    <link>https://www.tellmeproject.eu/content/tamiflu-and-relenza-effectiveness-questioned-cochrane-collaboration-and-bmj</link>
    <description>&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; property=&quot;content:encoded&quot;&gt;&lt;p&gt;There is no good evidence about the effectiveness of Tamiflu (oseltamivir) and Relenza (zanamivir) for influenza prevention and treatment. This is the tough claim made by Cochrane Collaboration and the British Medical Journal (BMJ), based on the extended systematic review they just published about the use of neuraminidase inhibitors against influenza.&lt;/p&gt;&lt;p&gt;Their study is entirely based on complete clinical study reports, trial registries, electronic databases, regulatory archives and correspondence with manufacturers, which correspond to more than 150,000 pages of documents; more specifically, the&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-tags field-type-taxonomy-term-reference field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Tags:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/antiviral-therapies&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Antiviral Therapies&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/antivirals&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Antivirals&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/oseltamivir&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Oseltamivir&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/zanamivir&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;zanamivir&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description>
     <pubDate>Thu, 10 Apr 2014 06:00:23 +0000</pubDate>
 <dc:creator>amministratore</dc:creator>
 <guid isPermaLink="false">251 at https://www.tellmeproject.eu</guid>
  </item>
  </channel>
</rss>
